Stocks · News reference

8-K filing — NRC HEALTH (NRC)

Aug 11, 2026, 8:31 PMSEC EDGAR

Filed: 2026-08-11 AccNo: 0001437749-26-027031 Size: 152 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

NRC

Source: edgar
Observed: Aug 11, 2026, 8:31 PM
Checked: Aug 11, 2026, 8:31 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 11, 2026, 8:59 PMBenzinga Newsdesk
On Aug 7, Shane Harrison, CFO of NRC Health, Tendered Resignation From The Co.; Resignation Effective As August 28, 2026
On August 7, 2026, Shane Harrison, Chief Financial Officer and principal financial officer of NRC Health, a Delaware corporation (the "Company"), tendered his resignation from the Company in order to pursue an
Read original at benzinga
NRC
BenzingaJul 29, 2026, 2:05 PMBenzinga Newsdesk
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26
Read original at benzinga
NRC
BenzingaJul 28, 2026, 8:04 PMBenzinga Newsdesk
National Research Q2 Adj. EPS $0.31 Beats $0.14 Estimate, Sales $35.392M Beat $34.900M Estimate
National Research (NASDAQ:NRC) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.14 by 121.43 percent. This is a 10.71 percent increase over earnings of $0.28 per share from
Read original at benzinga
NRC

8-K filing — NRC HEALTH (NRC)

Connected markets

Related headlines

On Aug 7, Shane Harrison, CFO of NRC Health, Tendered Resignation From The Co.; Resignation Effective As August 28, 2026

Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

National Research Q2 Adj. EPS $0.31 Beats $0.14 Estimate, Sales $35.392M Beat $34.900M Estimate